Coronary Artery Revascularization Evaluation (CARE), A Multi-Center Registry


Sponsor: HCA
              Medtronic, Inc.
              Guidant

Investigators:
Michael Mack, MD*
Tea Acuff, MD
Phil Brown, MD
Karamat Choudhry, MD
Allan Anderson, MD
David Brown, MD
Eric Eichhorn, MD
James Edgerton, MD
David Cohen, MD
Marc Katz, MD
Frank Houser
Jay Midwall, MD
Aaron D. Kugelmass, MD
George Palmer, MD

Designated Sites:
Medical City Dallas
Denton Regional Medical
Henrico Doctors' Hospital
Central Florida Regional Hospital
Centennial Medical Center
Plaza Medical Center
JFK Medical Center
Medical Center Plano


The purpose of this trial is to look at real world applications of drug-eluting stents and off pump CABG surgery in centers where both are clinically available for use. This retrospective study will compare procedural outcomes and direct health care costs for 5 years following coronary revascularization in four groups of patients:

• Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) • PCI with bare-metal stents • Coronary artery bypass grafting (CABG) using cardiopulmonary bypass pump • CABG performed on patients without the use of coronary bypass pump

All patients undergoing a coronary revascularization procedure at the clinical sites will be enrolled in the study at the time the procedure is performed. Each site will obtain IRB approval with a waiver of authorization for this study. Patients will be classified into one of the four study groups based on the coronary revascularization procedure they are undergoing.

* denotes Principal Investigator